相似文献
1
Synthesis of biphenyl proteomimetics as estrogen receptor-alpha coactivator binding inhibitors.
Org Lett. 2009 Dec 3;11(23):5370-3. doi: 10.1021/ol901999f.
2
3,3'-Disubstituted bipolar biphenyls as inhibitors of nuclear receptor coactivator binding.
Bioorg Med Chem Lett. 2012 Nov 1;22(21):6587-90. doi: 10.1016/j.bmcl.2012.09.007. Epub 2012 Sep 13.
3
4,4'-Unsymmetrically substituted 3,3'-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors.
Bioorg Med Chem. 2014 Jan 15;22(2):917-26. doi: 10.1016/j.bmc.2013.10.051. Epub 2013 Nov 8.
4
Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.
J Med Chem. 2004 Jan 29;47(3):600-11. doi: 10.1021/jm030404c.
5
Biphenyls as surrogates of the steroidal backbone. Part 1: synthesis and estrogen receptor affinity of an original series of polysubstituted biphenyls.
Bioorg Med Chem Lett. 2001 Jul 9;11(13):1709-12. doi: 10.1016/s0960-894x(01)00267-0.
6
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
Bioorg Med Chem Lett. 2008 Aug 1;18(15):4433-7. doi: 10.1016/j.bmcl.2008.06.028. Epub 2008 Jun 12.
7
ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives.
Bioorg Med Chem. 2004 May 15;12(10):2553-70. doi: 10.1016/j.bmc.2004.03.028.
8
Design and synthesis of biphenyl derivatives as mushroom tyrosinase inhibitors.
Bioorg Med Chem. 2010 Sep 15;18(18):6708-14. doi: 10.1016/j.bmc.2010.07.062. Epub 2010 Aug 1.
9
Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
J Steroid Biochem Mol Biol. 2003 Nov;87(2-3):141-8. doi: 10.1016/j.jsbmb.2003.07.005.
10
Discovery of aryl-biphenyl-2-ylmethylpiperazines as novel scaffolds for 5-HT(7) ligands and role of the aromatic substituents in binding to the target receptor.
Bioorg Med Chem. 2013 May 1;21(9):2568-76. doi: 10.1016/j.bmc.2013.02.038. Epub 2013 Mar 6.
引用本文的文献
1
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation-Drug leads for metastatic castration resistant prostate cancer.
SLAS Discov. 2023 Oct;28(7):325-343. doi: 10.1016/j.slasd.2023.08.001. Epub 2023 Aug 6.
2
Anion-Dominated Copper Salicyaldimine Complexes-Structures, Coordination Mode of Nitrate and Decolorization Properties toward Acid Orange 7 Dye.
Polymers (Basel). 2020 Aug 24;12(9):1910. doi: 10.3390/polym12091910.
3
Steroid receptor/coactivator binding inhibitors: An update.
Mol Cell Endocrinol. 2019 Aug 1;493:110471. doi: 10.1016/j.mce.2019.110471. Epub 2019 Jun 1.
4
Perfluoro-tert-butyl Homoserine Is a Helix-Promoting, Highly Fluorinated, NMR-Sensitive Aliphatic Amino Acid: Detection of the Estrogen Receptor·Coactivator Protein-Protein Interaction by F NMR.
Biochemistry. 2017 Feb 28;56(8):1062-1074. doi: 10.1021/acs.biochem.6b01020. Epub 2017 Feb 15.
5
Molecular Pathways: Targeting Steroid Receptor Coactivators in Cancer.
Clin Cancer Res. 2016 Nov 15;22(22):5403-5407. doi: 10.1158/1078-0432.CCR-15-1958. Epub 2016 Sep 21.
6
Reconfiguring the AR-TIF2 Protein-Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen.
Assay Drug Dev Technol. 2016 Oct;14(8):453-477. doi: 10.1089/adt.2016.741. Epub 2016 Sep 8.
7
The Role of Steroid Receptor Coactivators in Hormone Dependent Cancers and Their Potential as Therapeutic Targets.
Horm Cancer. 2016 Aug;7(4):229-35. doi: 10.1007/s12672-016-0261-6. Epub 2016 Apr 28.
8
In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
Breast Cancer Res. 2015 Feb 25;17(1):27. doi: 10.1186/s13058-015-0529-8.
9
4,4'-Unsymmetrically substituted 3,3'-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors.
Bioorg Med Chem. 2014 Jan 15;22(2):917-26. doi: 10.1016/j.bmc.2013.10.051. Epub 2013 Nov 8.
10
Synthesis of a tetrasubstituted tetrahydronaphthalene scaffold for α-helix mimicry via a MgBr2-catalyzed Friedel-Crafts epoxide cycloalkylation.
Org Lett. 2013 Sep 20;15(18):4892-5. doi: 10.1021/ol402334j. Epub 2013 Sep 9.
本文引用的文献
1
A set of time-resolved fluorescence resonance energy transfer assays for the discovery of inhibitors of estrogen receptor-coactivator binding.
J Biomol Screen. 2009 Feb;14(2):181-93. doi: 10.1177/1087057108329349. Epub 2009 Feb 4.
2
Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding.
J Med Chem. 2008 Oct 23;51(20):6512-30. doi: 10.1021/jm800698b. Epub 2008 Sep 12.
3
Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interaction.
ACS Chem Biol. 2008 May 16;3(5):282-6. doi: 10.1021/cb800056r.
4
Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.
J Med Chem. 2008 Mar 27;51(6):1925-44. doi: 10.1021/jm701324c. Epub 2008 Feb 29.
5
Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides.
Angew Chem Int Ed Engl. 2007;46(24):4471-3. doi: 10.1002/anie.200700657.
6
Synthetic non-peptide mimetics of alpha-helices.
Chem Soc Rev. 2007 Feb;36(2):326-34. doi: 10.1039/b608043j. Epub 2007 Jan 4.
7
Synthesis and structure-activity relationship study of antidiabetic penta-O-galloyl-D-glucopyranose and its analogues.
J Med Chem. 2006 May 4;49(9):2829-37. doi: 10.1021/jm060087k.
8
Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.
Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:10-20. doi: 10.1007/s00280-005-0108-2.
9
Protein surface recognition and proteomimetics: mimics of protein surface structure and function.
Curr Opin Chem Biol. 2005 Dec;9(6):632-8. doi: 10.1016/j.cbpa.2005.10.006. Epub 2005 Oct 18.
10
Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer.
Breast Cancer Res. 2005;7(5):205-11. doi: 10.1186/bcr1287. Epub 2005 Jul 20.
Zotero 插件